Jin Jian Huang
Financieel Directeur/CFO bij CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.
Profiel
Jin Jian Huang is currently the Director at QYH Biotech Co., Ltd.
and the Chief Financial & Accounting Officer at China Animal Husbandry Industry Co., Ltd.
He previously worked as a Director at Xiamen Kingdomway Group Co. and as the Board Secretary & Chief Accountant at Zhongnongfa Seed Industry Group Co., Ltd.
Mr. Huang obtained an undergraduate degree from Anhui Finance & Trade College.
Actieve functies van Jin Jian Huang
| Bedrijven | Functie | Begin |
|---|---|---|
| CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. | Financieel Directeur/CFO | 31-08-2018 |
QYH Biotech Co., Ltd.
 QYH Biotech Co., Ltd. BiotechnologyHealth Technology QYH Biotech Co., Ltd. engages in the research, development, and production of vaccines for major animal diseases such as highly pathogenic avian influenza and highly pathogenic swine blue ear disease. The company was founded on July 1, 2004 and is headquartered in Beijing. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Jin Jian Huang
| Bedrijven | Functie | Einde |
|---|---|---|
| ZHONGNONGFA SEED INDUSTRY GROUP CO., LTD. | Comptroller/Controller/Auditor | 31-08-2018 |
| XIAMEN KINGDOMWAY GROUP COMPANY | Directeur/Bestuurslid | - |
Opleiding van Jin Jian Huang
| Anhui Finance & Trade College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ZHONGNONGFA SEED INDUSTRY GROUP CO., LTD. | Distribution Services |
| XIAMEN KINGDOMWAY GROUP COMPANY | Health Technology |
| CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
QYH Biotech Co., Ltd.
QYH Biotech Co., Ltd. BiotechnologyHealth Technology QYH Biotech Co., Ltd. engages in the research, development, and production of vaccines for major animal diseases such as highly pathogenic avian influenza and highly pathogenic swine blue ear disease. The company was founded on July 1, 2004 and is headquartered in Beijing. | Health Technology |
